Back to Top

Cancer Investigation (JSN)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Cancer Investigation
  • Clinical studies
  • precision oncology
  • +4

e-ISSN :

1532-4192

Issue Frequency :

10-issues-year

Impact Factor :

1.8

p-ISSN :

0735-7907

Est. Year :

2025

Mobile :

4402080520500

DOI :

YES

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

google scholar

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Cancer Investigation is a well-established, international journal publishing research on all aspects of oncology. Disseminating research for more than four decades, the journal aims to provide researchers and clinicians with a comprehensive resource on the current state of progress in the field of oncology, as well as a broad background of reliable information necessary for effective decision-making. Cancer Investigation provides a unique, nimble, cutting-edge publishing platform for a broad range of topics spanning the spectrum of oncology and the rapidly changing landscape of oncology.


Cancer Investigation (JSN) is :

International, Peer-Reviewed, Open Access, Refereed, Cancer Investigation, Clinical studies, precision oncology, genomic medicine, novel technologies, Art of Medicine, letters to the editor , Online or Print, 10-issues-year Journal

UGC Approved, ISSN Approved: P-ISSN - 0735-7907, E-ISSN - 1532-4192, Established in - 2025, Impact Factor - 1.8

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Publications of JSN

  • dott image January, 2025

The Pittsburgh Sleep Quality Index (PSQI) Applied to Cancer Patients: Psychometric Properties and Factors Affecting Sleep Quality

Objective Cancer patients frequently report sleep problems. The Pittsburgh Sleep Quality Index (PSQI) is a 19-item instrument for assessing sleep problems. The main objective of this study ...

  • dott image January, 2025

Weather-Related Factors and Patient-Reported Outcomes (PROs) in Cancer Patients: Results from the ExPRO Study

Objective The ExPRO (External factors influencing patient reported outcomes of patients with malignant diseases) study explored associations between QoL data and environmental factors on th...

  • dott image November, 2025

LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape

Background To investigate the effects of LDHB on lactylation of programmed cell death 1 ligand (PD-L1) and immune evasion of ovarian cancer. Methods Ovarian cancer cells were transfecte...

  • dott image Xiaochen WU
  • dott image July, 2024

Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembol...

Despite the emergence of various treatment strategies for rectal cancer based on neoadjuvant chemoradiotherapy, there is currently a lack of reliable biomarkers to determine which patients w...

  • dott image June, 2024

Barthel Index and Age as Predictors of Discharge Destination in Patients with Glioblastoma

This study aimed to investigate the predictive factors of transfer of glioblastoma multiforme (GBM) patients who underwent rehabilitation in acute care hospitals. We retrospectively identifi...

  • dott image Shengfen Zhang
  • dott image June, 2024

A Bioinformatic Analysis of Gut Microbiota Related with Immune Cell Infiltration in Colorectal Cancer

Objective The composition of microbiota which correlates with infiltrating immune cells and clinical signatures is not clarified in CRC. Methods We applied 4 kinds of bioinformatic tool...

Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test

Evaluation of the test performance of the Target enhanced whole-genome sequencing (TE-WGS) assay for comprehensive oncology genomic profiling. The analytical validation of the assay included...

  • dott image May, 2024

Identifying Optimal Candidates for Primary Tumor Resection Among Metastatic Pancreatic Cancer Patients: A Population-Based Predictive Model

Background There is a controversy about whether surgery should proceed among metastatic pancreatic cancer (mPC) patients. A survival benefit was observed in mPC patients who underwent prima...

  • dott image Xiangyu Zhao
  • dott image April, 2024

A 15-Inflammation-Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Adenocarcinoma

Chronic inflammation promotes the development of pancreatic ductal adenocarcinoma (PDAC) and PDAC-related inflammatory tumor microenvironment facilitates tumor growth and metastasis. Thus, w...

  • dott image December, 2023

Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review

Background New biomarkers of progression in patients with prostate cancer (PCa) are needed to improve their classification and clinical management. This systematic review investigated the r...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile